Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0921 | 1 | 1 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0162 | 0.022 | 0.022 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0335 | 0.2455 | 0.3708 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0704 | 0.7207 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0268 | 0.1585 | 0.1585 |
Loa Loa (eye worm) | hypothetical protein | 0.0791 | 0.8332 | 1 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0148 | 0.004 | 0.004 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0392 | 0.3192 | 0.3192 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0457 | 0.4018 | 0.4018 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0471 | 0.4204 | 0.4204 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.019 | 0.0588 | 0.0588 |
Loa Loa (eye worm) | fatty acid synthase | 0.0465 | 0.4124 | 0.4318 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.05 | 0.4581 | 0.4581 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.05 | 0.4581 | 0.4581 |
Mycobacterium ulcerans | thioesterase | 0.0392 | 0.3192 | 0.3192 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0471 | 0.4204 | 0.4204 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0849 | 0.9077 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0379 | 0.3018 | 0.4155 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0704 | 0.7207 | 0.7207 |
Brugia malayi | oxidoreductase, zinc-binding dehydrogenase family protein | 0.0893 | 0.964 | 1 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.05 | 0.4581 | 0.4581 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0471 | 0.4204 | 0.4361 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0921 | 1 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0921 | 1 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.05 | 0.4581 | 0.4581 |
Loa Loa (eye worm) | hypothetical protein | 0.0264 | 0.1535 | 0.0823 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0311 | 0.2148 | 0.2148 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.0338 | 0.2495 | 0.2495 |
Brugia malayi | AMP-binding enzyme family protein | 0.044 | 0.3806 | 0.3948 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0921 | 1 | 0.5 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.05 | 0.4581 | 0.4581 |
Mycobacterium ulcerans | polyketide synthase | 0.05 | 0.4581 | 0.4581 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0471 | 0.4204 | 0.581 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.044 | 0.3806 | 0.3806 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0148 | 0.004 | 0.004 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0311 | 0.2148 | 0.2148 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0385 | 0.3098 | 0.3098 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0379 | 0.3018 | 0.3018 |
Mycobacterium ulcerans | thioesterase TesA | 0.0392 | 0.3192 | 0.3192 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0921 | 1 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0379 | 0.3018 | 0.3018 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.044 | 0.3806 | 0.3889 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0457 | 0.4018 | 0.4018 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.05 | 0.4581 | 0.6337 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0471 | 0.4204 | 0.581 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0471 | 0.4204 | 0.4204 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0471 | 0.4204 | 0.4204 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0921 | 1 | 1 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0392 | 0.3192 | 0.4398 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0921 | 1 | 0.5 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0704 | 0.7207 | 0.7207 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0311 | 0.2148 | 0.2941 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0471 | 0.4204 | 0.4204 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.05 | 0.4581 | 1 |
Onchocerca volvulus | 0.082 | 0.87 | 0.9285 | |
Mycobacterium ulcerans | polyketide synthase | 0.0471 | 0.4204 | 0.4204 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0471 | 0.4204 | 0.4204 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0704 | 0.7207 | 0.7207 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0471 | 0.4204 | 0.4204 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0306 | 0.2072 | 0.2574 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.05 | 0.4581 | 0.6337 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.05 | 0.4581 | 0.6337 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI (functional) | = 32 % | Growth inhibition of human MCF7 cells at 20 uM after 48 hrs by MTT assay | ChEMBL. | 22277074 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.